Writer Emma Hislop has been named as the recipient of the 2023 New Zealand-Australia residency exchange with Australia. We’re pleased to work with the Michael King Writers Centre to support this residency through our Partnership Fund.
New Zealand writer Emma Hislop has been announced as the recipient of the 2023 New Zealand-Australia residency exchange, an international residency programme held by Varuna, the Australian National Writers House in collaboration with the Michael King Writers Centre in Auckland.
Copyright Licensing New Zealand is pleased to support this residency through our Partnership Fund, which has been supporting projects that align with its objectives.
The four-week residency exchange will take place during September and October 2023 and Emma will work on her latest book, a novel, at Varuna and will appear at the Blue Mountains Writers Festival.
Emma (Kaī Tahu) is a Taranaki based writer. Her first book of short fiction, Ruin, was published in March 2023 with Te Herenga Waka University Press. She has an MA with Distinction from the IIML and in 2021 she was awarded the Louis Johnson New Writers Bursary. Emma is part of Te Hā Taranaki, a collective for Māori writers, established in 2019.
This residency programme is supported by Copyright Licensing New Zealand and the Australia Council for the Arts.
Chair of the Board of Trustees, Melanie Laville-Moore says ‘Losing professional international opportunities has been a tough consequence for many of our established writers in Aotearoa. The Michael King Writers Centre is delighted with this important partnership with Varuna House in Australia, and enabling a New Zealand writer four weeks in the idyllic Blue Mountains of New South Wales during the spring of 2023.
More on the Partnership Fund
Our CLNZ Partnership Fund is aimed at partnering with sector groups that are connecting to, or working with, diverse voices and communities to support publishing sector projects with grants that range in value from $2,000 to $5,000. Take a look at the Partnership Fund guidelines and criteria here.